PEGGY WEST: Open Payments
NPI 1720160773 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 16 payments from 10 companies in 2025. Trend: 2023 $1,194 · 2024 $929 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| ABBVIE INC. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| PFIZER INC. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Ozempic, AREXVY, UBRELVY, GEMTESA, JARDIANCE, ZENPEP, AIRSUPRA, MOUNJARO.
Industry payments across OH — which companies pay providers there.
